G.J. Ossenkoppele

Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia

Markus Pfirrmann, Michele Baccarani, Joëlle Guilhot et al. · Leukemia · 2015 · 289 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Oncology +9

Immunohistochemical profiling based on Bcl‐2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma

JJF Muris, CJLM Meijer, W Vos et al. · The Journal of Pathology · 2006 · 232 citations

Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group.

Bob Löwenberg, Stefan Suciu, E Archimbaud et al. · PubMed · 1997 · 206 citations

Aberrant marker expression patterns on the CD34+CD38− stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission

Anna van Rhenen, Bijan Moshaver, Angèle Kelder et al. · Leukemia · 2007 · 185 citations

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +9

MRD parameters using immunophenotypic detection methods are highly reliable in predicting survival in acute myeloid leukaemia

N Feller, M.A. van der Pol, Amber van Stijn et al. · Leukemia · 2004 · 182 citations · Full text

Hematological Malignancy, Oncology, Immunophenotypic Detection Methods +13